Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Potential Retinal Biomarkers in Alzheimer's Disease

García-Bermúdez MY, Vohra R, Freude K, Wijngaarden PV, Martin K, Thomsen MS, Aldana BI, Kolko M.

Int J Mol Sci. 2023 Oct 31;24(21):15834. doi: 10.3390/ijms242115834.

Alzheimer's Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor

Le PG, Choi SH, Cho S.

Biosensors (Basel). 2023 Nov 17;13(11):987. doi: 10.3390/bios13110987.

Circulating arginine metabolites in Alzheimer's disease and vascular dementia: A systematic review and meta-analysis

Zinellu A, Tommasi S, Sedda S, Mangoni AA.

Ageing Res Rev. 2023 Dec;92:102139. doi: 10.1016/j.arr.2023.102139. Epub 2023 Nov 23.

Physical Performance and Amyloid-β in Humans: A Systematic Review and Meta-Analysis of Observational Studies

Solis-Urra P, Rodriguez-Ayllon M, Álvarez-Ortega M, Molina-Hidalgo C, Molina-Garcia P, Arroyo-Ávila C, García-Hermoso A, Collins AM, Jain S, Gispert JD, Liu-Ambrose T, Ortega FB, Erickson KI, Esteban-Cornejo I.

J Alzheimers Dis. 2023;96(4):1427-1439. doi: 10.3233/JAD-230586.

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z.

Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.

Validating blood tests as a possible routine diagnostic assay of Alzheimer's disease

Kodosaki E, Zetterberg H, Heslegrave A.

Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1153-1165. doi: 10.1080/14737159.2023.2289553. Epub 2023 Dec 15.

Cerebrospinal and Blood Biomarkers in Alzheimer's Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?

Bivona G, Iemmolo M, Ghersi G.

Int J Mol Sci. 2023 Nov 29;24(23):16908. doi: 10.3390/ijms242316908.

Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease

Nordengen K, Kirsebom BE, Richter G, Pålhaugen L, Gísladóttir B, Siafarikas N, Nakling A, Rongve A, Bråthen G, Grøntvedt GR, Gonzalez F, Waterloo K, Sharma K, Karikari T, Vromen EM, Tijms BM, Visser PJ, Selnes P, Kramberger MG, Winblad B, Blennow K, Fladby T.

J Neuroinflammation. 2023 Dec 13;20(1):298. doi: 10.1186/s12974-023-02973-w.

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum

Lehmann S, Schraen-Maschke S, Vidal JS, Blanc F, Paquet C, Allinquant B, Bombois S, Gabelle A, Delaby C, Hanon O; BALTAZAR Study Group.

Int J Mol Sci. 2023 Dec 11;24(24):17361. doi: 10.3390/ijms242417361.

Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?

Souchet B, Michaïl A, Billoir B, Braudeau J.

Int J Mol Sci. 2023 Dec 16;24(24):17544. doi: 10.3390/ijms242417544.

The Role of CSF Transthyretin in Human Alzheimer's Disease: Offense, Defense, or not so Innocent Bystander

Buxbaum JN.

J Integr Neurosci. 2023 Nov 6;22(6):158. doi: 10.31083/j.jin2206158.

Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer's disease

Singh R, Kaur N, Dhingra N, Kaur T.

Int J Neurosci. 2023 Jul;133(7):714-734. doi: 10.1080/00207454.2021.1968859. Epub 2022 May 21.

Using second life to teach health professions students about Alzheimer's Disease: A comprehensive review

Barros Una L, Brangman S, Indelicato A, Krueger A, Ludwig A, Slutzky AR, Stewart T, Germain LJ.

Gerontol Geriatr Educ. 2023 Apr-Jun;44(2):243-253. doi: 10.1080/02701960.2021.2022660. Epub 2022 Jan 7.

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

Yin F.

FEBS J. 2023 Mar;290(6):1420-1453. doi: 10.1111/febs.16344. Epub 2022 Jan 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias